A compound of formula (I) or a pharmaceutically acceptable salt thereof, processes for their preparation, pharmaceutical compositions containing them and their use in therapy, for example in the treatment of proliferative disease such as cancer and particularly in disease mediated by an mTOR kinase and/or one or more PI3K enzyme.
申请公布号
WO2009007749(A2)
申请公布日期
2009.01.15
申请号
WO2008GB50547
申请日期
2008.07.08
申请人
ASTRAZENECA AB;ASTRAZENECA UK LIMITED;FINLAY, MAURICE, RAYMOND, VERSCHOYLE
